Abstract
Background As COVID-19 Omicron variant spread in several countries, healthcare workers’ (HCWs) perceptions of vaccine effectiveness, booster and worries warrant reassessment.
Methods Online questionnaire among HCWs in Saudi Arabia (KSA) was collected between Dec 1-6, 2021, aiming to assess their Omicron variant’s perceptions, worries, and booster-vaccine advocacy.
Results Among the 1285 HCWs participants in the study, two-thirds were females, 41% were nurses,46.4% were physicians, and 50% worked in tertiary care hospitals. Vaccination was perceived to be the most effective way to prevent the spread of Omicron variant and future variants by 66.9%. The respondents perceived social distancing (78%), universal masking (77.8%), and avoiding unnecessary travel (71.4%), slightly superior to vaccination to prevent COVID-19 variants spread. Of the respondents, 99.5% received two doses of COVID-19 vaccine. Regarding the booster dose, 96% either received it or planned to receive it once they are eligible. 57.7% of the respondents agreed that Omicron could cause a new COVID-19 wave worldwide, 45.9% agreed it may cause another COVID-19 wave in Saudi Arabia and 46.1% indicated the possibility of another lockdown. Overall, the HCWs worry level of the Omicron variant correlated significantly and strongly with their perception of the effectiveness of vaccination and preventive measures. Male HCWs had a significant agreement with mandatory vaccination of all eligible adult populations while HCWs who are unwilling to receive the vaccine had a strong disagreement with mandatory vaccination.
Conclusions The current study was conducted in the first week of Omicron variant discovery in KSA and only two-thirds of HCWs felt that vaccination is the best option to prevent the variant spread, indicating the need to further motivation campaigns for vaccination and booster doses education among HCWs. HCWs had a strong belief in non-pharmacologic interventions that should be encouraged and augmented. It is important to further study and enhance coping strategies for HCWs as we move through the third year of the pandemic with more potential variants, to protect HCWs from fatigue and burnout.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of King Saud University gave ethical approval for this work (approval 21/01039/IRB).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author emails Fadi Aljamaan: PO BOX 2925, Riyadh 11461, Saudi Arabia faljamaan{at}ksu.edu.sa
Shuliweeh Alenezi: PO BOX 7747, Riyadh, 13321 salenizi{at}ksu.edu.sa
Khalid Alhasan: PO BOX 2925, Riyadh 11461, Saudi Arabia kalhasan{at}ksu.edu.sa
Abdulkarim Alrabiaah alrabiaah{at}KSU.EDU.SA
Rasha Assiri raassiri{at}pnu.edu.sa
Rolan Bassrawi rkbassrawi{at}ksu.edu.sa,
Ali Alhaboob (AAH): PO BOX 2925, Riyadh 11461, Saudi Arabia drhbooob{at}gmail.com
Fatimah Alshahrani : Falshahrani1{at}ksu.edu.sa
Mohamad Alarabi : PO BOX 2925, Riyadh 11461, Saudi Arabia malarabi{at}ksu.edu.sa
Ali Alaraj (AAA): PO BOX 12471, Riyadh, Saudi Arabia al_araj{at}hotmail.com
Naser S Alharbi nsalharbi{at}ksu.edu.sa
Rabih Halwani: rhalwani{at}sharjah.ac.ae
Amr Jamal amrjamal{at}ksu.edu.sa
Ayman AL-Eyadhy aleyadhy{at}ksu.edu.sa
Naif Abdulmajeed Dr.naifq{at}gmail.com
Lina Alfarra Lalfarra19811{at}gmail.com
Wafa almashdali Almashdali{at}gmail.com
Fahad Al-Zamil fzamil{at}KSU.EDU.SA
Mazin Barry mbarry{at}ksu.edu.sa
Ziad Memish zmemish{at}yahoo.com
Jaffar A. Al-Tawfiq jaltawfi{at}yahoo.com
Sarah Al-Subaie salsubaie{at}ksu.edu.sa
Conflict of interest: None declared.
Ethics approval and consent to participate: The study was approved by the institutional review board of King Saud University (approval 21/01039/IRB).
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author.
Abbreviations
- CDC
- Centers for Disease Control and Prevention
- COVID-19
- Coronavirus disease 2019
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- WHO
- World Health Organization
